ANAVEX LIFE SCIENCES CORP. financial data

Symbol
AVXL on Nasdaq
Location
New York, NY
Fiscal year end
30 September
Latest financial report
10-Q - Q4 2025 - 09 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 11% % 6.8%
Return On Equity -39% % -3.4%
Return On Assets -35% % -2.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 89,348,107 shares 5.3%
Common Stock, Shares, Outstanding 92,671,758 shares 9%
Entity Public Float $708,000,000 USD 72%
Common Stock, Value, Issued $93,000 USD 9.4%
Weighted Average Number of Shares Outstanding, Basic 89,029,458 shares 5%
Weighted Average Number of Shares Outstanding, Diluted 89,029,458 shares 5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $31,802,000 USD -27%
General and Administrative Expense $12,796,000 USD 11%
Operating Income (Loss) $44,598,000 USD 19%
Nonoperating Income (Expense) $4,669,000 USD -46%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $43,002,000 USD 9.5%
Income Tax Expense (Benefit) $18,000 USD
Net Income (Loss) Attributable to Parent $39,947,000 USD 14%
Earnings Per Share, Basic -0.46 USD/shares 16%
Earnings Per Share, Diluted -0.46 USD/shares 16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $131,749,000 USD 9.1%
Assets $132,989,000 USD 7.2%
Accounts Payable, Current $2,639,000 USD -42%
Accrued Liabilities, Current $2,927,000 USD -62%
Liabilities $6,371,000 USD -51%
Retained Earnings (Accumulated Deficit) $388,129,000 USD -11%
Stockholders' Equity Attributable to Parent $126,618,000 USD 14%
Liabilities and Equity $132,989,000 USD 7.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $7,151,000 USD 41%
Net Cash Provided by (Used in) Financing Activities $36,323,000 USD 5030%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 92,671,758 shares 9%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $131,749,000 USD 9.1%
Deferred Tax Assets, Valuation Allowance $108,492,000 USD 18%
Deferred Tax Assets, Gross $20,700,000 USD 37%
Deferred Tax Assets, Operating Loss Carryforwards $54,752,000 USD 14%
Current Income Tax Expense (Benefit) $59,000 USD -79%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Share-based Payment Arrangement, Expense $10,500,000 USD 14%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%